Organization · Venture Capital
cultivate(MD)
cultivate(MD) is a medical device venture capital fund based in Grand Rapids, Michigan, focusing on early-stage investments in healthcare technologies that enhance outcomes and reduce costs. The fund leverages deep operational expertise to engage with portfolio companies.
Overview
What cultivate(MD) does
What cultivate(MD) is
cultivate(MD) is a medical device venture capital fund based in Grand Rapids, Michigan, focusing on early-stage investments in healthcare technologies that enhance outcomes and reduce costs. The fund leverages deep operational expertise to engage with portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find cultivate(MD) elsewhere
Open the official website or a supported primary organization account.
Capability profile
cultivate(MD) as a funder
Investment thesis
cultivate(MD) focuses on early-stage medical device investments, leveraging deep operational expertise to add value through technical competence and financial resources.
Focus narrative
cultivate(MD) invests in early-stage medical device companies, emphasizing technologies that improve healthcare outcomes and reduce costs. Their investment strategy includes Seed and Accelerator Funds, as well as an Opportunity Fund for follow-on investments in existing portfolio companies.
Value beyond capital
cultivate(MD) adds value to its portfolio companies through active operational engagement, leveraging its team's technical expertise and industry connections to support product development, regulatory strategy, and commercialization efforts.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Medical Devices · Surgical Robotics · Digital Health · Regenerative Medicine
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
- Recorded notable exits
- Imascap, SPDx, and Shoulder Innovations
Portfolio context
Notable portfolio companies include: Embody, Inc.: A regenerative medicine company focused on developing implantable medical devices for soft tissue restoration and regeneration. Acquired in 2023. Imascap: Develops software for preoperative planning of shoulder replacement surgery. Acquired in 2017. Shoulder Innovations: Creator of the InSet™ Total Shoulder Replacement System, addressing fixation issues in shoulder arthroplasty. Planned IPO on July 31, 2025. SPDx: Provides sterile processing and logistic support to enhance revenue capacity in surgical facilities. Acquired in 2025.
Common questions
What to know about cultivate(MD)
Upseed classifies cultivate(MD) under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.